Join
Live feed
·
INSIDERFilingvia Quantisnow
Actinium Pharmaceuticals Inc. (Delaware) logo

Chief Executive Officer Seth Sandesh covered exercise/tax liability with 120,900 shares, decreasing direct ownership by 40% to 184,481 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATNM (Actinium Pharmaceuticals Inc. (Delaware)) and more on Quantisnow.